Last edition
News about Global Pharma
Esaote Unveils Two New Ultrasound Systems at Arab Health: MyLabA50 and MyLabA70
MyLab™A50 and MyLab™A70 embody the concept of Agility and are engineered to perform seamlessly in diverse clinical settings. With compact footprint, battery-operated lightweight and mobile design they meet the demands of most healthcare professionals.
Global Pharma | 29/01/2024 | By Manvi | 512
Glenmark Specialty S.A. (GSSA), a subsidiary of Glenmark Pharmaceuticals Ltd. (Glenmark) announced the signing of a license agreement with JIANGSU ALPHAMAB BIOPHARMACEUTICALS CO., LTD (Jiangsu Alphamab) and 3D MEDICINES INC. (3D Medicines), (together as the Licensors), for KN035 (Envafolimab) for India, Asia Pacific.
Global Pharma | 25/01/2024 | By Manvi | 666
MolecuLight Wins VA Contract for Advanced Wound Imaging Devices
This contract, facilitated through the VA FSS program, reinforces MolecuLight's commitment to addressing healthcare requirements for Veterans and other federal government agencies.
Global Pharma | 25/01/2024 | By Manvi | 239
SHL Medical, SteriPack Group Forms Partnership for Drug Delivery System Assembly Services
The collaboration aims to establish a pre-validated final assembly service at the SteriPack facility in Poland, offering enhanced flexibility in supply chain strategies for their customers.
Global Pharma | 24/01/2024 | By Manvi | 718
Seegene Announces Collaboration with Microsoft to Realize 'a World Free from All Diseases'
Seegene Inc. announced its selection of Microsoft as a technology partner for its SG OneSystemTM business in London, UK to realize 'a world free from all diseases.'
Global Pharma | 24/01/2024 | By Manvi | 476
Heron Therapeutics' ZYNRELEF Receives FDA Approval for Expanded Surgical Indication
The expanded indication covers soft tissue and orthopedic surgical procedures, including foot and ankle, and others avoiding direct exposure to articular cartilage.
Global Pharma | 24/01/2024 | By Manvi | 897
Amadix's PreveCol Colorectal Cancer Screening Test Granted FDA Breakthrough Device Designation
This recognition positions Amadix as the first European company to achieve such status for early detection of colorectal cancer.
Global Pharma | 23/01/2024 | By Manvi | 674
Pharma Logistics Appoints David A. Hargraves as CEO
In response to the transition, Zaccaro expressed confidence in Hargraves' ability to lead Pharma Logistics into a future marked by growth and innovation.
Global Pharma | 23/01/2024 | By Manvi | 482
Sandoz to Bolster Ophthalmology Portfolio Through Acquisition of CIMERLI Biosimilar
The acquisition aligns with Sandoz's dedication to providing expanded treatment options for US patients dealing with vision impairment and loss.
Global Pharma | 22/01/2024 | By Manvi | 717
Progeria Research Foundation's Zokinvy Receives Approval in Japan for Progeria Treatment
PRF, a pioneering force in rare disease research, has been at the forefront of Zokinvy clinical trial research since 2007.
Global Pharma | 22/01/2024 | By Manvi | 556
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy